SERPINA1 and alpha 1-antitrypsin deficiency: A 34-year-old woman, affected by severe bronchial asthma and AATD, Z/Mwhitestable genotype with AAT serum level of 57 mg/dL, was on treatment with AAT augmentation therapy at the dose of 60 mg/kg/week for approximately 2 years.